Kodiak Sciences Stock (NASDAQ:KOD)

USA |NASDAQ |USD

Price
$86.22
Change
-2.20%
Today's Range
$86.20 - $87.87
52-Week Range
$73.19 - $171.21
Market Cap
$4.56B
Volume
1.58K

About Kodiak Sciences (NASDAQ:KOD)

(NASDAQ:KOD) Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biological agent that is in Phase 1b clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy. Its preclinical stage product candidate include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases. The company's early research pipeline include KSI-601, a triplet inhibitor for dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is headquartered in Palo Alto, California.
Show more

KOD Stock Price

Statistics Highlights (NASDAQ:KOD)

Shares Outstanding 51.72M Beta 1.46
Public Float 31.01M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 10.64% Ex-Dividend Date
Held by Institutions 88.87% IPO Date Oct 4, 2018

KOD Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue $0.00 $0.00 $0.00
EBITDA $-131.80M $-48.28M $-25.88M
Net Income $-133.10M $-47.37M $-41.44M
Total Assets $1.07B $358.87M $92.19M
Total Cash $944.40M $211.80M $88.25M
Total Debt $77.40M $1.94M $
Sep 21 Jun 21 Mar 21
Revenue $0.00 $0.00 $0.00
EBITDA $-65.35M $-53.67M $-48.25M
Net Income $-67.53M $-55.85M $-50.45M
Total Assets $958.21M $997.60M $1.03B
Total Cash $799.25M $880.87M $920.46M
Total Debt $78.96M $78.25M $77.66M

KOD Stock Price History

Kodiak Sciences Annual Stock Price History

Year Open Close Change
2022 $88.95 $86.22 -3.07%
2021 $151.33 $88.95 -41.22%
2020 $72.69 $151.33 108.19%

Kodiak Sciences Daily Stock Price History

Date Open High Low Close Change Volume
Jan 21, 2022 $59.48 $60.88 $56.19 $57.80 -4.37% 644.40K

(NASDAQ:KOD) Stock Price FAQs

What is today's stock price of Kodiak Sciences (NASDAQ:KOD)?

  • The current stock price of Kodiak Sciences (NASDAQ:KOD) is $86.22.
  • Today KOD stock price opened at $91.04 after previous close of $88.16.
  • During the day, Kodiak Sciences stock quote has varied from a low of $86.20 to a high of $87.87.

What is Kodiak Sciences's 52-week change?

  • KOD 52-week high stock quote is $171.21, which is 98.60% above the current share price.
  • The Kodiak Sciences (NASDAQ:KOD) 52-week low stock price is $73.19, which is 15.10% below the current share price.
  • Kodiak Sciences share price volatility (52-week beta) is 1.46.

Is Kodiak Sciences a buy?

  • According to 10 analysts, the current consensus recommendation for Kodiak Sciences stock is "Buy" at an average rating score of 3.80 (out of 5).
  • There are currently 4 "Strong Buy", 1 "Buy", 4 "Hold", 1 "Sell", and 0 "Strong Sell" analysts recommendations for the KOD stock.
  • The 12 month average price target forecast for KOD stock is $126.10, representing a 46.30% increase from the current KOD stock price of $86.22.

Kodiak Sciences (NASDAQ:KOD) FAQ

How Much is Kodiak sciences Worth?

Kodiak sciences's worth today based on market capitalisation is $4.56B

How much dividend does Kodiak sciences Pay?

The current annualized dividend payout for KOD stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Kodiak sciences's "Dividend" Section

When is the next earnings date for Kodiak sciences (NASDAQ:KOD)?

Kodiak sciences is expected to report earnings on May 09 ,2022.
View More Details on Kodiak sciences's 'Earnings' Section

What is Kodiak sciences’s Price to Earning (PE) ratio?

KOD stock also has a Price to Sales (P/S) ratio of 0.00.

What is the Kodiak sciences's ticker?

Kodiak sciences trades on the NASDAQ stock market in USA under the ticker symbol "KOD". Kodiak sciences’s stock symbol can also be displayed as "NASDAQ:KOD".

When did KOD go public?

Kodiak sciences completed its initial public offering (IPO) on October 04 ,2018.

Who are the owners of Kodiak sciences?

Kodiak sciences (NASDAQ:KOD) is owned by 88.87% institutional shareholders and by 10.64% insiders. The rest is owned by the public.
The 3 top institutional shareholders are "Baker Bros Advisors LP", "T. Rowe Price Associates, Inc." and "Wellington Management Company LLP", representing 55.93% of Kodiak sciences’s total shares outstanding.
Explore More Details on Kodiak sciences's “Ownership” Section

Who are the key executives of Kodiak sciences (KOD)?

Kodiak sciences's key executive team includes the following managers:

  • Dr. Victor Perlroth M.D., Co-Founder, Chairman, CEO & Pres (1973)
  • Mr. John A. Borgeson CPA, M.B.A., MBA, CPA, Sr. VP, CFO & Sec. (1962)
  • Dr. Jason S. Ehrlich M.D., Ph.D., Chief Medical Officer & Chief Devel. Officer (1976)
  • Dr. Hong Liang, Sr. VP of Discovery Medicine (1972)
  • Ms. Almas Qudrat M.Sc., Sr. VP of Quality Operations (NA)

What is Kodiak sciences’s Sector & Industry Classification?

Kodiak sciences (NASDAQ:KOD) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Kodiak sciences?

Currently the number of employees working for Kodiak sciences is 85.

Where are Kodiak sciences's Headquarters?

Kodiak sciences (NASDAQ:KOD) is headquartered in CA, United States.

What are Kodiak sciences's Address and Phone Number?

Kodiak sciences’s mailing address is 1200 Page Mill Road, Palo Alto, CA, United States, 94304.
The company’s phone number is 650 281 0850.

What is the official website for Kodiak sciences?

Kodiak sciences’s official website is http://kodiak.com